State Surgeon General Dr. Joseph A. Ladapo has announced new guidance regarding mRNA vaccines. The Florida Department of Health conducted an analysis through a self-controlled case series, which is a technique originally developed to evaluate vaccine safety. This analysis found that there is an 84% increase in the relative incidence of cardiac-related death among males 18-39 years old within 28 days following mRNA vaccination.
COVID-19 Vaccine Information
Latest Vaccine Updates
The U.S. Food and Drug Administration updated the emergency use authorizations of the Pfizer-BioNTech and the Moderna vaccine for administration of a single booster at least two months after a primary or booster dose is given to help protect against the COVID-19 omicron variant. Adults aged 18 and up are eligible to receive the Moderna booster, while anyone 12 and up are eligible to receive the Pfizer-BioNTech booster.
The U.S. Food and Drug Administration authorized emergency use of the Moderna and Pfizer-BioNTech COVID-19 vaccine for the prevention of COVID-19 to include use in children down to six months of age. Enrolled providers are able to order COVID-19 vaccines for this age group through Florida SHOTS. Learn more.
The U.S. Food and Drug Administration (FDA) revised the Emergency Use Authorization (EUA) to discontinue the administration of sotrovimab. Bebtelovimab is Florida’s only available monoclonal antibody treatment.
Based on currently available data, healthy children aged 5-17 may not benefit from receiving the currently available COVID-19 vaccine. The Department recommends that children with underlying conditions are the best candidates for the COVID-19 vaccine. Learn more.
The U.S. Food and Drug Administration (FDA) revised the Emergency Use Authorizations (EUA) for Eli Lilly’s bamlanivimab-etesevimab and Regeneron’s REGEN-COV monoclonal antibody treatments, discontinuing their use by any U.S. state or jurisdiction. The full Florida Department of Health press release can be found here.
The CDC recommends that moderately or severely immunocompromised children 5-11 years old receive an additional primary dose of vaccine 28 days after their second shot. At this time, only the Pfizer-BioNTech vaccine is authorized and recommended for this use.
The CDC recommends that people can now receive a booster shot five months after completing their Pfizer-BioNTech primary series. The booster interval for people who received the Johnson & Johnson vaccine (two months) or the Moderna vaccine (six months), is unchanged.
Find Out if You’re Eligible for a Booster or Additional Dose
Booster shots and
increase your immune
COVID-19 Vaccine Communications Toolkit for Partner Organizations
The Florida Department of Health has designed a
communications toolkit to help your organization
build vaccine confidence
among the communities
Homebound COVID-19 Vaccination Program
Some Florida residents are unable to travel to a COVID-19 vaccination site due to
health or mobility reasons, but COVID-19 vaccines are still available for them. If
you are homebound and
would like to be scheduled for an in-home visit to
receive a COVID-19
vaccine, contact the
Vaccination Program at
Am I eligible for the
All Floridians are eligible to receive any COVID-19
vaccine as authorized by
the U.S. Food and Drug
Find COVID-19 vaccination sites near you.
Appointments may be required, and specific vaccine types and brands may not be available at all sites.Search Now
Total People Vaccinated
No. COVID-19 vaccines are free in Florida. No matter where you get the vaccine, whether from a state site, a church or a retail pharmacy like CVS or Publix, there is no charge.
The State of Florida continues to support and ensure adequate COVID-19 vaccine supply are widely available, including booster doses and additional doses. Individuals can talk to their health care provider about whether getting a COVID-19 vaccine booster dose or an additional dose is appropriate for them. The CDC determines eligibility for an additional doses and booster doses.
According to the CDC, a booster dose increases the immune response of individuals who have completed the recommended number of initial doses for a COVID-19 vaccine.
According to the CDC, an additional dose is to achieve a sufficient immune response among immunocompromised individuals.